Medicare Enrolled

Dr. Jorge Chaves, M.D.

Hematology & Oncology · Tacoma, WA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
1624 SOUTH I STREET, Tacoma, WA 98405
2533833366
Registered in NPPES since 2008
NPI: 1265610752 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chaves from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chaves? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chaves

Dr. Jorge Chaves is a hematology & oncology specialist in Tacoma, WA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Chaves performed 70,977 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Chaves received a total of $27,372 from 56 pharmaceutical and/or device companies across 204 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chaves is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years of NPI registration ▲ Top 4% volume in WA $27,372 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
70,977
Medicare services
Top 4% in WA for hematology & oncology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Filgrastim injection (Nivestym) for white blood cells
An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram.
16,620 $0 $2
Iron infusion (Feraheme)
An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis.
14,790 $0 $2
Anti-nausea injection (fosaprepitant)
An injection of fosaprepitant, a medication used to prevent nausea and vomiting.
12,000 $0 $0
Pembrolizumab injection (Keytruda) 7,800 $32 $62
Denosumab injection (Prolia/Xgeva) 2,280 $18 $34
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
1,524 $8 $13
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
1,504 $0 $2
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
1,491 $7 $15
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
1,392 $10 $21
Flow cytometry, additional marker
An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis.
1,147 $19 $65
Anti-nausea injection (Aloxi/palonosetron) 830 $1 $3
Anti-nausea injection (ondansetron/Zofran) 728 $0 $1
Injection, leucovorin calcium, per 50 mg 591 $3 $7
Lactate dehydrogenase (LDH) level test
A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease.
590 $6 $12
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
424 $91 $215
Fluorouracil injection, 500 mg
Administration of a 500 mg dose of fluorouracil medication via injection.
393 $2 $5
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
380 $12 $52
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
361 $127 $273
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
355 $103 $316
Carcinoembryonic antigen (CEA) level test
A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer.
326 $18 $36
Pegfilgrastim-jmdb injection
An injection of pegfilgrastim-jmdb, a biosimilar medication. The dose specified is 0.5 mg.
300 $98 $514
Immunoglobulin level test
A blood test that measures the level of gammaglobulins, which are immune system proteins.
290 $9 $14
Normal saline infusion, 500 ml
Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution.
263 $1 $2
Direct bilirubin level test
A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver.
255 $4 $9
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
253 $10 $35
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
249 $11 $52
Iron level test 246 $6 $13
Transferrin level test
A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body.
246 $12 $26
Glutamyltransferase (GGT) level test
A blood test that measures the level of the liver enzyme glutamyltransferase (GGT) to help evaluate liver health.
215 $6 $13
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
189 $6 $23
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
186 $9 $19
Total cortisol level test
A blood test that measures the total amount of cortisol hormone in your body. Cortisol is a hormone produced by the adrenal glands.
179 $16 $33
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
167 $16 $34
Ferritin level test (iron stores)
A blood test that measures the level of ferritin, a protein that stores iron in the body.
163 $13 $28
PSA test (prostate cancer screening) 161 $17 $35
Leuprolide acetate (for depot suspension), 7.5 mg 159 $128 $360
Complete blood count (CBC), automated
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood.
157 $6 $13
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
157 $23 $75
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
133 $50 $150
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
132 $14 $31
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
107 $1 $1
Enhanced Oncology Model monthly payment
This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients.
103 $72 $70
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
98 $22 $75
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
91 $93 $212
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
90 $51 $160
Intravenous hydration infusion, 31-60 minutes
Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes.
87 $23 $110
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
66 $27 $100
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
64 $66 $146
Magnesium level test
A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess.
58 $2 $5
Normal saline infusion, 1000 cc
Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution.
58 $2 $3
Irrigation of implanted venous access device
This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids.
53 $18 $55
Flow cytometry DNA or cell analysis, first marker
A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell.
50 $58 $140
Folic acid level test
A blood test that measures the amount of folic acid in the serum.
47 $14 $29
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
47 $136 $409
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
44 $2 $4
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
39 $16 $48
IV chemotherapy initiation with community continuation
Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living.
37 $137 $250
Concurrent intravenous infusion
Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given.
32 $16 $45
New patient office visit, complex (60-74 min) 32 $169 $415
Blood sample collection from implanted device
This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body.
30 $20 $41
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
24 $1 $2
SARS-CoV-2 immunoassay test
A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus.
19 $31 $81
Sed rate test (inflammation marker)
This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body.
18 $3 $6
Venipuncture for blood collection
A procedure to draw blood from a vein for medical testing or analysis.
18 $70 $202
Bone marrow biopsy and aspiration
A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions.
15 $122 $260
Automated red blood cell count with calculations
A blood test that automatically counts red blood cells and performs additional calculations to assess blood health.
13 $5 $12
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
11 $125 $331
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
22.5% high complexity
62.3% medium
15.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$27,372
Total received (2018-2024)
Avg $3,910/year across 7 years
Top 13% in WA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
204
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$980
2023
$6,901
2022
$1,303
2021
$6,385
2020
$9,365
2019
$569
2018
$1,868

Payments by company (2024)

Merck Sharp & Dohme LLC
$146
ABBVIE INC.
$143
Stemline Therapeutics Inc.
$81
AstraZeneca Pharmaceuticals LP
$76
BeiGene USA, Inc.
$66
Regeneron Healthcare Solutions, Inc.
$49
Daiichi Sankyo Inc.
$48
PFIZER INC.
$47
Takeda Pharmaceuticals U.S.A., Inc.
$45
Eisai Inc.
$44
Genentech USA, Inc.
$44
Agios Pharmaceuticals, Inc.
$39
Astellas Pharma US Inc
$29
Janssen Biotech, Inc.
$23
Deciphera Pharmaceuticals Inc.
$20
Lilly USA, LLC
$18
TerSera Therapeutics LLC
$18
EMD Serono, Inc.
$15
Genmab U.S., Inc.
$14
Ipsen Biopharmaceuticals, Inc
$14
Top 3 companies account for 37.8% of 2024 payments
All-time payments by company (2018-2024) ›
Ipsen Biopharmaceuticals, Inc
$7,640
Epizyme, Inc.,
$3,509
AstraZeneca Pharmaceuticals LP
$2,904
Merck Sharp & Dohme Corporation
$2,707
Janssen Biotech, Inc.
$2,675
Kite Pharma, Inc.
$1,700
Karyopharm Therapeutics Inc.
$1,550
G1 Therapeutics, Inc.
$1,525
E.R. Squibb & Sons, L.L.C.
$358
Pharmacyclics LLC, An AbbVie Company
$278
Merck Sharp & Dohme LLC
$211
ABBVIE INC.
$143
Novartis Pharmaceuticals Corporation
$125
BeiGene USA, Inc.
$110
Lilly USA, LLC
$101
Genentech USA, Inc.
$101
Eisai Inc.
$98
Daiichi Sankyo Inc.
$96
Incyte Corporation
$92
Celgene Corporation
$92
Regeneron Healthcare Solutions, Inc.
$86
PFIZER INC.
$85
Agios Pharmaceuticals, Inc.
$84
Stemline Therapeutics Inc.
$81
Astellas Pharma US Inc
$71
Takeda Pharmaceuticals U.S.A., Inc.
$63
GENZYME CORPORATION
$58
EMD Serono, Inc.
$57
Bayer HealthCare Pharmaceuticals Inc.
$56
SANOFI-AVENTIS U.S. LLC
$51
MEDIVATION FIELD SOLUTIONS LLC
$50
Deciphera Pharmaceuticals Inc.
$50
Exelixis Inc.
$44
AbbVie Inc.
$42
Clovis Oncology, Inc.
$34
Seattle Genetics, Inc.
$32
Seagen Inc.
$30
Amgen Inc.
$29
Rigel Pharmaceuticals, Inc.
$28
JAZZ PHARMACEUTICALS INC.
$27
Aadi Bioscience, Inc.
$24
Pharmacyclics LLC, an AbbVie Company
$24
CTI BioPharma Corp.
$23
Dova Pharmaceuticals
$23
Melinta Therapeutics, Inc.
$23
Kyowa Kirin, Inc.
$21
Mirati Therapeutics, Inc.
$21
TAIHO ONCOLOGY, INC.
$20
Jazz Pharmaceuticals Inc.
$18
Aurobindo Pharma USA, Inc.
$18
TerSera Therapeutics LLC
$18
Lexicon Pharmaceuticals, Inc.
$16
Genmab U.S., Inc.
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Coherus Biosciences Inc.
$13
Gilead Sciences, Inc.
$12
Top 3 companies account for 51.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BESPONSA · BOSULIF · BRUKINSA · CABOMETYX · COSELA · CYRAMZA · Columvi · DARZALEX · Doptelet · ELREXFIO · ENHERTU · EPKINLY · Enhertu · Epkinly · FRUZAQLA · Folotyn · Fyarro · GILOTRIF · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LENVIMA · LIBTAYO · LONSURF · LUTATHERA · LYNPARZA · Lenvima · MONJUVI · Neulasta · Nplate · ONIVYDE · OPDIVO · OPDUALAG · Onivyde · Orbactiv · Orserdu · POTELIGEO · PREVYMIS · PROMACTA · Padcev · Perjeta · QINLOCK · REBLOZYL · RYDAPT · Reblozyl · Rezlidhia · Rubraca · SPRYCEL · TAFINLAR · TAZVERIK · TECVAYLI · TEPMETKO · TEVIMBRA · TIBSOVO · TUKYSA · Tecartus · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vitrakvi · Vonjo · XPOVIO · XTANDI · Xermelo · ZEPZELCA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Tacoma?
Compare hematology & oncology specialists in the Tacoma area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
52
County median income
$96,632
Nearest hospital to ZIP centroid (approximate)
ST JOSEPH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chaves is a mixed practice specialist, with above-average Medicare volume (top 4% in WA), with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chaves experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Chaves performed 16,620 filgrastim injection (nivestym) for white blood cells services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Chaves receive payments from pharmaceutical companies?
Yes. Dr. Chaves received a total of $27,372 from 56 companies across 204 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chaves's costs compare to other hematology & oncology specialists in Tacoma?
Dr. Chaves's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chaves) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →